1. Avoid use of NSAIDs during pregnancy; contraindicated in 3rd trimester

   News item 10 September 2022 Pages: 1 - 1

2. Genetic analysis of drug-induced interstitial lung disease in Japan

   News item 10 September 2022 Pages: 2 - 2

3. Jamp-Atorvastatin Calcium lot recalled in Canada

   News item 10 September 2022 Pages: 3 - 3

4. Nebulised asthma therapy at home should be guided by specialist

   News item 10 September 2022 Pages: 4 - 4

5. Risk of finasteride-related suicidal ideation

   News item 10 September 2022 Pages: 5 - 5

6. Risk of liver failure with Maviret, Vosevi or Zepatier

   News item 10 September 2022 Pages: 6 - 6

7. Darolutamide AE costs lower versus apalutamide or enzalutamide

   Clinical study 10 September 2022 Pages: 7 - 7

8. Medsafe reviews risk of anticoagulant-related abnormal uterine bleeding

   News item 10 September 2022 Pages: 8 - 8

9. Muscle symptoms in patients treated with statins

   Clinical study 10 September 2022 Pages: 9 - 9

10. Revision of precautions for hypnotic agents due to parasomnia

    News item 10 September 2022 Pages: 10 - 10

11. Safety profile of BBV152 COVID-19 vaccine favourable in adolescents in India

    Clinical study 10 September 2022 Pages: 11 - 11

12. TTS rare after AstraZeneca COVID-19 vaccine

    Clinical study 10 September 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 10 September 2022 Pages: 13 - 13

14. β-adrenergic receptor antagonists

    Case report 10 September 2022 Pages: 14 - 14

15. Acalabrutinib/ibrutinib

    Case report 10 September 2022 Pages: 15 - 15

16. Aceclofenac/etidronic acid

    Case report 10 September 2022 Pages: 16 - 16

17. Acenocoumarol/antiplatelets/antithrombotics

    Case report 10 September 2022 Pages: 17 - 17

18. Ad26.cov2-s

    Case report 10 September 2022 Pages: 18 - 18

19. Ad26.COV2-S

    Case report 10 September 2022 Pages: 19 - 19

20. Ad26.cov2-s/methylprednisolone

    Case report 10 September 2022 Pages: 20 - 20

21. Adalimumab/azathioprine/infliximab

    Case report 10 September 2022 Pages: 21 - 21

22. Adalimumab/etanercept

    Case report 10 September 2022 Pages: 22 - 22

23. Albendazole/levamisole/measles vaccine

    Case report 10 September 2022 Pages: 23 - 23

24. Alectinib/lenvatinib

    Case report 10 September 2022 Pages: 24 - 24

25. Alfentanil/morphine

    Case report 10 September 2022 Pages: 25 - 25

26. Allopurinol

    Case report 10 September 2022 Pages: 26 - 26

27. Allopurinol/everolimus/flucloxacillin

    Case report 10 September 2022 Pages: 27 - 27

28. Alogliptin

    Case report 10 September 2022 Pages: 28 - 28

29. Alteplase

    Case report 10 September 2022 Pages: 29 - 29

30. Amikacin

    Case report 10 September 2022 Pages: 30 - 30

31. Amikacin/immunosuppresants

    Case report 10 September 2022 Pages: 31 - 31

32. Amiloride/magnesium

    Case report 10 September 2022 Pages: 32 - 32

33. Amiodarone

    Case report 10 September 2022 Pages: 33 - 33

34. Amiodarone

    Case report 10 September 2022 Pages: 34 - 34

35. Amisulpride/olanzapine

    Case report 10 September 2022 Pages: 35 - 35

36. Amoxicillin/clavulanic-acid/azithromycin

    Case report 10 September 2022 Pages: 36 - 36

37. Amoxicillin/clavulanic-acid/azithromycin

    Case report 10 September 2022 Pages: 37 - 37

38. Amphotericin-b-liposomal

    Case report 10 September 2022 Pages: 38 - 38

39. Amphotericin-B-liposomal/caspofungin/fluconazole

    Case report 10 September 2022 Pages: 39 - 39

40. Analgesics/corticosteroids/methylprednisolone

    Case report 10 September 2022 Pages: 40 - 40

41. Analgesics/mirtazapine/olanzapine

    Case report 10 September 2022 Pages: 41 - 41

42. Antibacterials

    Case report 10 September 2022 Pages: 42 - 42

43. Antibacterials/azithromycin

    Case report 10 September 2022 Pages: 43 - 43

44. Anticoagulants/immune-globulin/steroids

    Case report 10 September 2022 Pages: 44 - 44

45. Antiepileptic-drugs

    Case report 10 September 2022 Pages: 45 - 45

46. Antihypercalcaemics/cinacalcet/prednisone

    Case report 10 September 2022 Pages: 46 - 46

47. Antihypertensive/immunosuppressant

    Case report 10 September 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 10 September 2022 Pages: 48 - 48

49. Antineoplastics

    Case report 10 September 2022 Pages: 49 - 49

50. Antineoplastics

    Case report 10 September 2022 Pages: 50 - 50